CLAINT: Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens.

Sponsor
Faculty Hospital Kralovske Vinohrady (Other)
Overall Status
Recruiting
CT.gov ID
NCT05697978
Collaborator
Očni centrum Praha a.s. (Other), Somich, s.r.o. (Other)
100
3
1
10
33.3
3.3

Study Details

Study Description

Brief Summary

To get the visual outcomes for distance and intermediate and binocular defocus curve in patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision LLC) at 3 months after the surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Monofocal intraocular lens Clareon (Alcon LLC)
N/A

Detailed Description

The goal of refractive cataract surgery is to remove the opacity, or cataract and to produce the desired refractive outcome. In most cases, the desired outcome is an emmetropic eye, or an eye that sees 20/20 Snellen for distance vision post-surgery with the implant of a monofocal IOL. This, however, does not offer much in the way of intermediate and near vision. The increased desire for simultaneous distance, intermediate and near vision has increased the popularity of multifocal IOLs (MIOLs). However MIOLs provide visual acuity for all distances, they has occurence of optical phenomena such as glare and halo and lower contrast sensitivity. Extended depth of focus (EDOF) lens should provide distance vision as good as monofocal lens and intermediate vision better than monofocal but without or with less appearance of optical phenomenon or decreased contrast sensitivity.

This study is prospective, multi-center, conducted from 10/2022 to 08/2023 in the Ophthalmology department of Faculty Hospital Kralovske Vinohrady in Prague, in Eye Center Prague and Eye Clinic SOMICH (Karlovy Vary). The research protocol was explained to all participants and informed consent was signed before enrolling patient to the study. The study was approved by the Ethics Committee of Faculty Hospital Kralovske Vinohrady and will enrolled up to 100 patients with presence of cataract in both eyes.

Bilateral clear corneal phacoemulsification and IOL implantation is performed by two experienced surgeon using the same technique in both eyes. The surgical process involved topical anesthesia, superior 3-step clear corneal incision (2,2mm), 5,0mm curvilinear capsulorhexis, phacoemulsification, bilateral irrigation- aspiration and implantation of monofocal aspheric intraocular lens (Clareon Alcon vision LLC).

Patients are scheduled for visit at 3 months after the surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
each patient in group received monofocal intraocular lens in both eyeseach patient in group received monofocal intraocular lens in both eyes
Masking:
None (Open Label)
Masking Description:
no masking
Primary Purpose:
Treatment
Official Title:
Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens.
Actual Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Monofocal lens

Eyes of patients with implanted monofocal aspheric lens Clareon (Alcon LLC)

Device: Monofocal intraocular lens Clareon (Alcon LLC)
monofocal aspheric lens implanted in eyes of patient during routine cataract surgery

Outcome Measures

Primary Outcome Measures

  1. Monocular corrected Distance Visual Acuity (CDVA) [3 months]

    Monocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.

  2. Binocular corrected Distance Visual Acuity (CDVA) [3 months]

    Binocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.

  3. Monocular uncorrected intermediate visual acuity (UIVA) [3 months]

    Monocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

  4. Binocular uncorrected intermediate visual acuity (UIVA) [3 months]

    Binocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

  5. Monocular distance corrected intermediate visual acuity (DCIVA) [3 months]

    Monocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

  6. Binocular distance corrected intermediate visual acuity (DCIVA) [3 months]

    Binocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

Secondary Outcome Measures

  1. Binocular defocus curve [3 months]

    A defocus curve that measures visual acuity should be obtained by using the best corrected distance refraction and then defocusing the image in 0.5 increments from +1.5 to -3.0 diopter with spherical plus and spherical minus trial lenses (i.e.,+1.5 D, +1.0 D, +0.5 D, 0.00 D, -0.5 D, -1.00 D, . . . ,-2.50 D) with visual acuity recorded at each change in correction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • presence of cataract in both eyes

  • no other ocular pathology affecting visual acuity

  • bilateral phacoemulsification cataract surgery was arranged for both eyes

  • corneal astigmatism up to 0,5 cylinder (measured by IOL Master biometry)

  • dioptric power of both selective lens within 1,5 D range in one patient

  • selecting IOL power between 15 D and 28 D power range

Exclusion Criteria:
  • complicated cataract

  • corneal opacities or irregularities

  • amblyopia

  • anisometropia

  • coexisting ocular pathologies

  • glaucoma

  • history of ocular surgery

  • refusal or unable to maintain follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Center Prague Prague Czech Republic Czechia 11000
2 Faculty hospital Kralovske Vinohrady Prague Czech Republic Czechia 11000
3 Somich Eye Clinic Karlovy Vary Czechia 36001

Sponsors and Collaborators

  • Faculty Hospital Kralovske Vinohrady
  • Očni centrum Praha a.s.
  • Somich, s.r.o.

Investigators

  • Principal Investigator: Andrea Janekova, MD, Eye Center Prague

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrea Janekova, MD, Faculty Hospital Kralovske Vinohrady
ClinicalTrials.gov Identifier:
NCT05697978
Other Study ID Numbers:
  • CZ-001
First Posted:
Jan 26, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Janekova, MD, Faculty Hospital Kralovske Vinohrady

Study Results

No Results Posted as of Jan 26, 2023